BỘ Y TẾ
CỤC QUẢN LÝ DƯỢC
-------

CỘNG HÒA XÃ HỘI CHỦ NGHĨA VIỆT NAM
Độc lập - Tự do - Hạnh phúc
---------------

Số: 817/QLD-MP
V/v cập nhật quy định về các chất sử dụng trong mỹ phẩm

Hà Nội, ngày 19 tháng 01 năm 2023

Kính gửi:

- Sở Y tế các tỉnh, thành phố trực thuộc Trung ương
- Các cơ sở sản xuất, kinh doanh mỹ phẩm

Nơi nhận:
- Như trên;
- Thứ trưởng Đỗ Xuân Tuyên (để b/c);
- Cục trưởng Cục QLD (để b/c);
- Thanh tra Bộ (để phối hợp);
- VKN thuốc TW, VKN thuốc Tp.HCM;
- Các Phó Cục trưởng (để biết);
- Phòng PC-TTr, Website Cục QLD;
- Lưu: VT, MP.

KT. CỤC TRƯỞNG
PHÓ CỤC TRƯỞNG




Tạ Mạnh Hùng

STT

Tên chất

Số Tham chiếu/ Số Phụ lục (Annex)

Ngày áp dụng

1

Octamethylcyclotetrasiloxane; D4

1388/Annex II

21/11/2024

2

Sodium perborate [1]; Sodium peroxometaborate; sodium peroxoborate [2]

1397/Annex II

21/11/2024

3

Perboric acid (H3BO2(O2)), monosodium salt trihydrate [1]; Perboric acid, sodium salt, tetrahydrate [2]; Perboric acid (HBO(O2)), sodium salt, tetrahydrate sodium peroxoborate hexahydrate [3]

1398/Annex II

21/11/2024

4

Perboric acid, sodium salt [1]; Perboric acid, sodium salt, monohydrate [2]; Perboric acid (HBO(O2)), sodium salt, monohydrate [3]

1399/Annex II

21/11/2024

5

Nickel diformate [1]; Formic acid, nickel salt [2]; Formic acid, copper nickel salt [3]

1428/Annex II

21/11/2024

6

Nickel barium titanium primrose priderite; C.I. Pigment Yellow 157; C.I. 77900

1458/Annex II

21/11/2024

7

Nickel dichlorate [1]; Nickel dibromate [2]; Ethyl hydrogen sulfate, nickel(II) salt [3]

1459/Annex II

21/11/2024

8

Trisodium nitrilotriacetate

1490/Annex II

21/11/2024

9

Cyclohexylamine

1503/Annex II

21/11/2024

10

Cobalt

1645/Annex II

21/11/2024

11

Metaldehyde (ISO); 2,4,6,8-tetramethyl-1,3,5,7-tetraoxacyclooctane

1646/Annex II

21/11/2024

12

Methylmercuric chloride

1647/Annex II

21/11/2024

13

Benzo[rst]pentaphene

1648/Annex II

21/11/2024

14

Dibenzo[b,def]chrysene; dibenzo[a,h]pyrene

1649/Annex II

21/11/2024

15

Ethanol, 2,2'-iminobis-, N- (C13-15-branched and linear alkyl) derivs.

1650/Annex II

21/11/2024

16

Cyflumetofen (ISO); 2-methoxyethyl (RS)-2- (4-tert-butylphenyl)-2-cyano-3-oxo-3-(α,α,α-trifluoro- o-tolyl)propionate

1651/Annex II

21/11/2024

17

Diisohexyl phthalate

1652/Annex II

21/11/2024

18

halosulfuron-methyl (ISO); methyl 3- chloro-5-{[(4,6- dimethoxypyrimidin-2- yl) carbamoyl] sulfamoyl}-1- methyl-1H-pyrazole-4- carboxylate

1653/Annex II

21/11/2024

19

2-methylimidazole

1654/Annex II

21/11/2024

20

Metaflumizone (ISO); (EZ)-2'-[2-(4-cyanophenyl)-1-(α,α,α - trifluoro-m- tolyl)ethylidene]-[4- (trifluoromethoxy)phenyl] carbanilohydrazide [E-isomer ≥ 90 %, Z- isomer ≤ 10 % relative content]; [1] (E)-2'-[2-(4-cyanophenyl)- 1-(α,α,α - trifluoro-m-tolyl) ethylidene]-[4- (trifluoromethoxy)phenyl] carbanilohydrazide [2]

1655/Annex II

21/11/2024

21

Dibutylbis(pentane-2,4- dionato-O,O’)tin

1656/Annex II

21/11/2024

22

Silicon carbide fibres (with diameter < 3 μm, length > 5 μm and aspect ratio ≥ 3:1)

1658/Annex II

21/11/2024

23

Tris(2-methoxyethoxy) vinylsilane; 6-(2-methoxyethoxy)- 6-vinyl-2,5,7,10- tetraoxa-6-silaundecane

1659/Annex II

21/11/2024

24

Dioctyltin dilaurate; [1] stannane, dioctyl-, bis (coco acyloxy) derivs. [2]

1660/Annex II

21/11/2024

25

Dibenzo[def,p]chrysene; dibenzo[a,l]pyrene

1661/Annex II

21/11/2024

26

Ipconazole (ISO); (1RS,2SR,5RS;1RS,2SR,5SR)-2-(4-chlorobenzyl)-5-isopropyl-1- (1H-1,2,4- triazol-1-ylmethyl) cyclopentanol

1662/Annex II

21/11/2024

27

Bis(2-(2-methoxyethoxy)ethyl)ether; tetraglyme

1663/Annex II

21/11/2024

28

Paclobutrazol (ISO); (2RS,3RS)-1-(4-chlorophenyl)-4,4-dimethyl- 2-(1H-1,2,4-triazol-1- yl)pentan-3-ol

1664/Annex II

21/11/2024

29

2,2-bis(bromomethyl) propane-1,3-diol

1665/Annex II

21/11/2024

30

2-(4-tert-butylbenzyl) propionaldehyde

1666/Annex II

21/11/2024

31

Diisooctyl phthalate

1667/Annex II

21/11/2024

32

2-methoxyethyl acrylate

1668/Annex II

21/11/2024

33

Flurochloridone (ISO); 3-chloro-4- (chloromethyl)-1-[3- (trifluoromethyl)phenyl]pyrrolidin-2-one

1671/Annex II

21/11/2024

34

3-(difluoromethyl)-1- methyl-N-(3',4',5'- trifluorobiphenyl-2-yl) pyrazole-4- carboxamide; fluxapyroxad

1672/Annex II

21/11/2024

35

N-(hydroxymethyl)acrylamide; methylolacrylamide; [NMA]

1673/Annex II

21/11/2024

36

5-fluoro-1,3-dimethyl-N-[2-(4- methylpentan-2-yl) phenyl]-1H- pyrazole- 4-carboxamide; 2'- [(RS)-1,3- dimethylbutyl]-5-fluoro-1,3- dimethylpyrazole-4-carboxanilide; penflufen

1674/Annex II

21/11/2024

37

Iprovalicarb (ISO); isopropyl [(2S)-3- methyl-1-{[1-(4- methylphenyl)ethyl] amino}-1-oxobutan-2- yl]carbamate

1675/Annex II

21/11/2024

38

Dichlorodioctylstannane

1676/Annex II

21/11/2024

39

Mesotrione (ISO); 2-[4- (methylsulfonyl)- 2-nitrobenzoyl]-1,3- cyclohexanedione

1677/Annex II

21/11/2024

40

Hymexazol (ISO); 3-hydroxy-5-methylisoxazole

1678/Annex II

21/11/2024

41

Imiprothrin (ISO); reaction mass of: [2,4- dioxo-(2-propyn-1-yl) imidazolidin-3-yl] methyl(1R)-cis- chrysanthemate; [2,4-dioxo-(2-propyn-1- yl) imidazolidin-3-yl] methyl(1R)-trans- chrysanthemate

1679/Annex II

21/11/2024

42

Bis(α,α-dimethylbenzyl) peroxide

1680/Annex II

21/11/2024

43

Salicylic acid

98/Annex III

3/Annex VI

21/11/2024

44

Titanium dioxide

CI 77891/Annex IV

27, 27a/Annex VII

21/11/2024